Laura Joszt, MA

Artificial intelligence (AI) and AI-enabled devices are already making their way into the market and should be able to help make meaning of data in order to improve care delivery, said speakers at the 15th Annual World Health Care Congress.

Tom Price, MD, former HHS secretary, identifies key principles to keep in mind as the political parties move forward with any health policy changes.

At the 15th Annual World Health Care Congress, CMS Administrator Seema Verma highlighted new policies and initiatives from CMS to ensure that programs are delivering high-quality care in a sustainable way as healthcare spending continues to grow at a faster rate than the overall US economy.

A shift in care delivery and the availability of data are helping to make value-based care a reality in the United States, but the change has been taking too long, said panelists at the 15th Annual World Health Care Congress.

Providing advanced home care can help reduce hospital admissions for the elderly, but these programs aren’t easy to get up and running, according to panelists at the spring 2018 conference of the National Association of ACOs.

Researchers have identified a new gene that may predispose individuals to develop acute lymphoblastic leukemia (ALL). In addition, variants in the gene can influence patient response to treatment.

There has been a proliferation of wearables from consumer gadgets, like the Fitbit, to medical devices that are approved by the FDA. Here are 5 things about wearable technology being used in healthcare.

There are 3 major components in the 21st Century Cures Act that will fix the technology challenges facing healthcare and accountable care organizations (ACOs), said Don Rucker, national coordinator of health information technology (IT) in HHS’ Office of the National Coordinator for Health IT, at the spring 2018 conference of the National Association of ACOs.

Climate change causes a host of issues that have public health impacts, and states are proactively taking steps to anticipate these health issues and prevent them.

A new tool has been created to measure patient uncertainty to predict which patients might return to the emergency department (ED) after discharge.

A new report suggests ways policy makers can support and advance value-based payment models so payment innovations can catch up to healthcare delivery innovations.

A new blood test could negate the need for bone biopsies to diagnose a variety of cancers, including multiple myeloma. The test uses a small, low-cost plastic chip that delivers the same diagnostic information of a biopsy through a simple blood draw.

Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders and chair-elect of the American Society of Clinical Oncology’s (ASCO) Clinical Practice Committee discusses the first results of the Oncology Care Model (OCM) and ASCO’s top legislative priorities.

Humana has launched a new maternity bundled payment model with 5 practices in Indiana, Kansas, Ohio, and Texas to improve quality, outcomes, and cost across the entire perinatal episode of care for women with low- to moderate-risk pregnancies.

With chimeric antigen receptor (CAR) T-cell therapy being so new, there is going to be a learning curve as providers become more educated about the treatments, the manufacturing process, and the toxicities, Houston Holmes, MD, MBA, FACP, a medical oncologist with Texas Oncology, explained at the Community Oncology Alliance’s (COA) 2018 Community Oncology Conference.

Divorce and socioeconomic status (SES)—measured by disposable income and education—predict patients who survived a heart attack who are at higher risk of a second event.

A novel drug that targets MDMX and MDM2, which inhibit a protein that suppresses tumors when they are overexpressed, has tripled the median survival rate in an animal model of human acute myeloid leukemia, according to new research.

Current policies being employed to limit spending can have serious consequences for patients, but a different benefit design approach could present an alternative strategy.

An analysis of a hypothetical bundled payment that included drug costs would unfairly penalize practices based on patient mix and could destabilize the cancer care delivery environment, according to research published in the Journal of Oncology Practice.

The identification of 40 genes involved with the development of multiple myeloma could lead to the development of more personalized treatments.

While increased risk of neurocognitive issues, such as long-term problems with attention, is common in survivors of childhood acute lymphoblastic leukemia (ALL), the risk may actually begin before treatment, according to a study published in JAMA Oncology.

A panel of providers discussed key advocacy issues that affect patients and practices and could improve access to care and costs during the 2018 Community Oncology Conference, hosted by the Community Oncology Alliance, April 12-13 in National Harbor, Maryland.

The Merit-based Incentive Payment System (MIPS) is a big program designed to be applied to all clinicians, which makes it complex to figure out how to do right, explained Richard Kane, senior director at Avalere.

Typically, cancer pain management is carved out of policies that try to restrict opioid prescribing in an effort to combat the opioid epidemic, but with more and more patients surviving their cancer, there is some uncertainty regarding who is affected by these policies, explained Bob Twillman, PhD, executive director for the Academy of Integrative Pain Management.

Papers from The Lancet's Taskforce of Non-Communicable Diseases analyzed the potential health and economic impact of implementing taxes on soda, alcohol, and tobacco to combat the rising rates of the chronic diseases worldwide.

The third annual population health survey from Numerof & Associates found that healthcare organizations have not made as much progress to transition to risk-based agreements as they predicted they would 2 years ago.

Once a decade, legislators try to fix healthcare in the United States. Panelists at PULSE: The Atlantic Summit on Health Care, discuss challenges to fixing healthcare and what solutions they see.

Neeraj Sood, PhD, discusses his research into the financial burdens associated with healthcare utilization for patients in consumer-directed health plans.

Surgeon General Jerome M. Adams, MD, issues a call for more people to carry naloxone to counteract opioid overdoses amid the ongoing national public health emergency; however, it is unclear if increased access to naloxone will combat the opioid epidemic or exacerbate overdoses.

Researchers have been trying to find a way to screen populations at high risk of developing a precursor condition to multiple myeloma in order to intervene early and reduce disease prevalence and mortality.